![First Trimester Screening for Trisomy 21 by Maternal Age, Nuchal Translucency and Fetal Nasal Bone in Unselected Pregnancies | IntechOpen First Trimester Screening for Trisomy 21 by Maternal Age, Nuchal Translucency and Fetal Nasal Bone in Unselected Pregnancies | IntechOpen](https://www.intechopen.com/media/chapter/18452/media/image11.png)
First Trimester Screening for Trisomy 21 by Maternal Age, Nuchal Translucency and Fetal Nasal Bone in Unselected Pregnancies | IntechOpen
![New cut-off values for screening of trisomy 21, 18 and open neural tube defects (ONTD) during the second trimester in pregnant women with advanced maternal age | BMC Pregnancy and Childbirth | Full Text New cut-off values for screening of trisomy 21, 18 and open neural tube defects (ONTD) during the second trimester in pregnant women with advanced maternal age | BMC Pregnancy and Childbirth | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12884-020-03464-z/MediaObjects/12884_2020_3464_Fig1_HTML.png)
New cut-off values for screening of trisomy 21, 18 and open neural tube defects (ONTD) during the second trimester in pregnant women with advanced maternal age | BMC Pregnancy and Childbirth | Full Text
![First Trimester Screening for Trisomy 21 by Maternal Age, Nuchal Translucency and Fetal Nasal Bone in Unselected Pregnancies | IntechOpen First Trimester Screening for Trisomy 21 by Maternal Age, Nuchal Translucency and Fetal Nasal Bone in Unselected Pregnancies | IntechOpen](https://www.intechopen.com/media/chapter/18452/media/image3.png)
First Trimester Screening for Trisomy 21 by Maternal Age, Nuchal Translucency and Fetal Nasal Bone in Unselected Pregnancies | IntechOpen
![The assessment of combined first trimester screening in women of advanced maternal age in an Asian cohort | SMJ The assessment of combined first trimester screening in women of advanced maternal age in an Asian cohort | SMJ](http://www.smj.org.sg/sites/default/files/SMJ-56-47-g003.jpg)
The assessment of combined first trimester screening in women of advanced maternal age in an Asian cohort | SMJ
![PDF] First-trimester risk calculation for trisomy 13, 18, and 21: comparison of the screening efficiency between 2 locally developed programs and commercial software. | Semantic Scholar PDF] First-trimester risk calculation for trisomy 13, 18, and 21: comparison of the screening efficiency between 2 locally developed programs and commercial software. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/a7d5b36f3aa2d8e0d07c528c8bc0752605231cbf/7-Table2-1.png)
PDF] First-trimester risk calculation for trisomy 13, 18, and 21: comparison of the screening efficiency between 2 locally developed programs and commercial software. | Semantic Scholar
![The rate of invasive testing for trisomy 21 is reduced after implementation of NIPT | Ugeskriftet.dk The rate of invasive testing for trisomy 21 is reduced after implementation of NIPT | Ugeskriftet.dk](https://content.ugeskriftet.dk/sites/default/files/styles/content/public/scientific_article/2018-08/a5359t01.jpg?itok=78CWsNcO)
The rate of invasive testing for trisomy 21 is reduced after implementation of NIPT | Ugeskriftet.dk
![Screening for trisomy 21 by maternal age, fetal nuchal translucency thickness, free beta‐human chorionic gonadotropin and pregnancy‐associated plasma protein‐A - Kagan - 2008 - Ultrasound in Obstetrics & Gynecology - Wiley Online Library Screening for trisomy 21 by maternal age, fetal nuchal translucency thickness, free beta‐human chorionic gonadotropin and pregnancy‐associated plasma protein‐A - Kagan - 2008 - Ultrasound in Obstetrics & Gynecology - Wiley Online Library](https://obgyn.onlinelibrary.wiley.com/cms/asset/83a8e63e-7352-42ea-b4e3-c381ebaf429c/mfig001.jpg)
Screening for trisomy 21 by maternal age, fetal nuchal translucency thickness, free beta‐human chorionic gonadotropin and pregnancy‐associated plasma protein‐A - Kagan - 2008 - Ultrasound in Obstetrics & Gynecology - Wiley Online Library
![Diagnostic value of maternal alpha-fetoprotein variants in second-trimester biochemical screening for trisomy 21 and 18 | Scientific Reports Diagnostic value of maternal alpha-fetoprotein variants in second-trimester biochemical screening for trisomy 21 and 18 | Scientific Reports](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41598-022-16807-x/MediaObjects/41598_2022_16807_Fig1_HTML.png)
Diagnostic value of maternal alpha-fetoprotein variants in second-trimester biochemical screening for trisomy 21 and 18 | Scientific Reports
![Table I from Screening for trisomies 21, 18 and 13 by maternal age, fetal nuchal translucency, fetal heart rate, free beta-hCG and pregnancy-associated plasma protein-A. | Semantic Scholar Table I from Screening for trisomies 21, 18 and 13 by maternal age, fetal nuchal translucency, fetal heart rate, free beta-hCG and pregnancy-associated plasma protein-A. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/278d84ba15efc27d74c3337c056ae60c590ee032/3-TableI-1.png)
Table I from Screening for trisomies 21, 18 and 13 by maternal age, fetal nuchal translucency, fetal heart rate, free beta-hCG and pregnancy-associated plasma protein-A. | Semantic Scholar
![Table II from Screening for trisomies 21, 18 and 13 by maternal age, fetal nuchal translucency, fetal heart rate, free beta-hCG and pregnancy-associated plasma protein-A. | Semantic Scholar Table II from Screening for trisomies 21, 18 and 13 by maternal age, fetal nuchal translucency, fetal heart rate, free beta-hCG and pregnancy-associated plasma protein-A. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/278d84ba15efc27d74c3337c056ae60c590ee032/3-TableII-1.png)